Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (231-240 of 408) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2014
Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in ItalyMarco Floridia, Giovanni Guaraldi, Marina Ravizza, et al.
HIV Clinical Trials|November 4, 2008
Factors influencing gestational age-adjusted birthweight in a national series of 600 newborns from mothers with HIVMarco Floridia, Marina Ravizza, Anna Bucceri, et al.
Antiviral Therapy|February 17, 2007
Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugsMarco Floridia, Enrica Tamburrini, Marina Ravizza, et al.
HIV Research & Clinical Practice|September 4, 2020
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIVStefan Adrian, Hongyu Miao, Han Feng, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2017
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIVAndrea De Luca, Patrizia Lorenzini, Antonella Castagna, et al.
Plos One|December 1, 2016
Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus InfectionJanice M Leung, Andrea Malagoli, Antonella Santoro, et al.
Atherosclerosis|July 15, 2009
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjectsGiovanni Guaraldi, Chiara Stentarelli, Stefano Zona, et al.
AIDS (London, England)|October 27, 2010
Surgical correction of HIV-associated facial lipoatrophyGiovanni Guaraldi, Joan Fontdevila, Lise H Christensen, et al.
Hepatology (Baltimore, Md.)|February 14, 2020
New Drugs for NASH and HIV Infection: Great Expectations for a Great NeedGiovanni Guaraldi, James B Maurice, Catia Marzolini, et al.
Pageof 41

Showing results (231-240 of 408) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2014
Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in ItalyMarco Floridia, Giovanni Guaraldi, Marina Ravizza, et al.
HIV Clinical Trials|November 4, 2008
Factors influencing gestational age-adjusted birthweight in a national series of 600 newborns from mothers with HIVMarco Floridia, Marina Ravizza, Anna Bucceri, et al.
Antiviral Therapy|February 17, 2007
Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugsMarco Floridia, Enrica Tamburrini, Marina Ravizza, et al.
HIV Research & Clinical Practice|September 4, 2020
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIVStefan Adrian, Hongyu Miao, Han Feng, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2017
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIVAndrea De Luca, Patrizia Lorenzini, Antonella Castagna, et al.
Plos One|December 1, 2016
Emphysema Distribution and Diffusion Capacity Predict Emphysema Progression in Human Immunodeficiency Virus InfectionJanice M Leung, Andrea Malagoli, Antonella Santoro, et al.
Atherosclerosis|July 15, 2009
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjectsGiovanni Guaraldi, Chiara Stentarelli, Stefano Zona, et al.
AIDS (London, England)|October 27, 2010
Surgical correction of HIV-associated facial lipoatrophyGiovanni Guaraldi, Joan Fontdevila, Lise H Christensen, et al.
Hepatology (Baltimore, Md.)|February 14, 2020
New Drugs for NASH and HIV Infection: Great Expectations for a Great NeedGiovanni Guaraldi, James B Maurice, Catia Marzolini, et al.
Pageof 41